Age and utilization of intensive care unit resources of critically ill cancer patients

Critical Care Medicine
D B Chalfin, G C Carlon

Abstract

Older patients, patients with malignancies, and those admitted to ICUs utilize a disproportionate amount of hospital resources. To evaluate the combined impact of age and a diagnosis of malignancy on ICU utilization and outcome, we reviewed the care provided to all 1,212 patients admitted to a medical/surgical ICU in a hospital specializing in the treatment of cancer between January 1, 1986 and December 31, 1987. Patients between 19 and 64 yr (young) were compared with those between 65 and 74 yr (young-old) and with those greater than or equal to 75 yr (old-old) with respect to utilization of nutritional support (total parenteral nutrition [TPN]), mechanical ventilation (MV), pulmonary artery (PA) catheterization, dialysis (D), and blood products (B). Mean length of stay (LOS) in the ICU, primary diagnosis, outcome, and average daily severity of illness scores (ADTIS) were also compared. Old-old patients represented 14% of all ICU patients and young-old patients represented 28%; 64% of old-old and 61% of young-old patients had solid tumors, compared with 36% of younger patients. The ICU mortality of the two older groups was significantly lower than that of the younger patients (17%, 27%, and 30%, respectively). The use of TPN, ...Continue Reading

Citations

Jun 1, 1991·Journal of Surgical Oncology·H R AlexanderJ Melendez
Mar 1, 1995·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·J P Sculier
Jun 10, 2003·Critical Care Medicine·Lakshmipathi ChelluriMichael R Pinsky
Oct 1, 2008·Critical Care Medicine·Jeremy M KahnDavid A Asch
Jan 26, 2005·Journal of the American Geriatrics Society·Ariane BoumendilUNKNOWN CUB-Rea Network
Dec 10, 1999·American Journal of Respiratory and Critical Care Medicine·J P KressJ B Hall
Jan 22, 1998·Intensive Care Medicine·S M Jakob, H U Rothen
Jan 16, 2003·Chest·John P GriffinUNKNOWN American College of Chest Physicians
Nov 16, 2013·Chest·Hayley B GershengornHannah Wunsch
Mar 8, 2006·Critical Care Medicine·Márcio SoaresNelson Spector
Apr 18, 2003·Critical Care Clinics·Ramesh Nagappan, Geoffrey Parkin
Mar 1, 2013·Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia·Hung-Chang LiuYu-Jen Chen
Mar 13, 2014·Journal of Critical Care·Gulbin AygencelMustafa Benekli
Aug 3, 2016·Journal of Critical Care·Ian M BallIan G Stiell
May 1, 1994·The British Journal of Surgery·H E MulcahyD P O'Donoghue
Jul 28, 2004·Critical Reviews in Oncology/hematology·Stefano Nava, Anna Maria Cuomo
May 25, 2011·Palliative Medicine·Siew Tzuh TangShu Chun Hsiao
Feb 1, 1996·AACN Clinical Issues·B K Shelton
Sep 25, 2009·The American Journal of Hospice & Palliative Care·Silvio A Namendys-SilvaAngel Herrera-Gómez
Nov 14, 2003·Intensive Care Medicine·Dominique SommeJean-Yves Fagon
Oct 12, 2011·Current Opinion in Critical Care·Scott D Halpern
Dec 29, 2016·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Ian M BallIan G Stiell
Jan 1, 1996·Journal of Intensive Care Medicine·K TewariK Waxman
Jan 1, 2007·Intensivmedizin + Notfallmedizin : Organ Der Deutschen Und Der Österreichischen Gesellschaft Für Internistische Intensivmedizin, Der Sektion Neurologie Der DGIM Und Der Sektion Intensivmedizin Im Berufsverband Deutscher Internisten E.V·S Zierhut, A Reichle
Nov 7, 2003·Critical Care Clinics·Kasra KaramlouCraig R Nichols

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.